KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Open Access
- 1 January 2012
- journal article
- practice guideline
- Published by The Korean Association for the Study of the Liver in Clinical and Molecular Hepatology
- Vol. 18 (2), 109-162
- https://doi.org/10.3350/cmh.2012.18.2.109
Abstract
The guideline on the management of chronic hepatitis B (CHB) was first developed in 2004 and revised in 2007 by the Korean Association for the Study of the Liver (KASL). Since then there have been many developments, including the introduction of new antiviral agents and the publications of many novel research results from both Korea and other countries. In particular, a large amount of knowledge on antiviral resistance--which is a serious issue in Korea--has accumulated, which has led to new strategies being suggested. This prompted the new guideline discussed herein to be developed based on recent evidence and expert opinion. The main targets of this guideline comprise patients who are newly diagnosed with CHB and those who are followed or treated for known CHB. This guideline is also intended to provide guidance for the management of patients under the following special circumstances: malignancy, transplantation, dialysis, coinfection with other viruses, pregnancy, and children.Keywords
This publication has 435 references indexed in Scilit:
- Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor liversHepatology International, 2010
- Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directionsHepatology International, 2010
- Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis CHepatology, 2009
- The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis BHepatology International, 2008
- Hepatitis B Immunoglobulin and Lamivudine Improve Hepatitis B–Related Outcomes After Liver Transplantation: Meta-AnalysisClinical Gastroenterology and Hepatology, 2008
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008
- Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)Hepatology International, 2008
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferonKidney International, 1995